NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit

NEW YORK, Sept. 6, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between May 7, 2025 and July 28, 2025, both dates inclusive (the "Class Period"), of the important September 30, 2025 lead...

Read More